Mindful  of the impending 2010 phase-out of certain controlled substances in Parties operating under paragraph 1 of Article 5,\xc2\xa0     Desiring  to implement effectively paragraph 7 of decision IV/25 and make the currently used essential-use exemption process and related decisions fully applicable to both Parties operating under paragraph 1 of Article 5, subject to the phase-out dates applicable to those Parties, and Parties not so operating,     Taking into consideration  that some Parties operating under paragraph 1 of Article 5 may prepare essential-use nominations for the first time and may therefore face difficulties in doing so,   1.\xc2\xa0\xc2\xa0 To make the following modifications to the decisions noted below:   (a)\xc2\xa0 To remove reference to the term \xe2\x80\x9cnot operating under Article 5\xe2\x80\x9d or, \xe2\x80\x9cfor non\xe2\x80\x91Article 5 Parties\xe2\x80\x9d from the following titles and provisions of the following past decisions of the Parties:      (i) \xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0Title of decisions VIII/9, VIII/10, VIII/11, XI/14, XVII/5, XVIII/7, XIX/13;  (ii)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision VIII/10, first line of paragraphs 1\xe2\x80\x939;   (iii)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XV/5, paragraphs 2, 3, 5(a) and 6;  (iv)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XVIII/7, paragraphs 2 and 3;  (v)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XVIII/16, first line of paragraph 7;      (b) To remove reference to the term \xe2\x80\x9cnot operating under Article 5 of the Montreal Protocol\xe2\x80\x9d from the following titles and provisions of the following past decisions of the Parties:    (i)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XVII/5, paragraph 2;   (ii)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XIX/13, paragraphs 2 and 3;     (c)\xc2\xa0 To remove and replace reference to the date \xe2\x80\x9c1996\xe2\x80\x9d with the term \xe2\x80\x9cphase-out\xe2\x80\x9d in the following provisions of past decisions of the Parties:    (i)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XVII/5, paragraph 2;   (ii)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XVIII/7, paragraph 2;\xc2\xa0\xc2\xa0   (iii)\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 Decision XIX/13, paragraph 2;      (d) To add a new paragraph after paragraph 3 of decision XVII/5 to read as follows:      3  bis \xc2\xa0 With reference to paragraph 6 of decision XV/5, to request that Parties operating under paragraph 1 of Article 5 of the Montreal Protocol submit a date to the Ozone Secretariat prior to the Twenty-Second Meeting of the Parties, by which time a regulation or regulations to determine the non\xe2\x80\x91essentiality of the vast majority of chlorofluorocarbons for metered-dose inhalers where the active ingredient is not solely salbutamol will have been proposed;     (e)\xc2\xa0 To add a new paragraph after paragraph 5 of decision IX/19 to read as follows:      5  bis.  To require Parties operating under paragraph 1 of Article 5 submitting essential-use nominations for chlorofluorocarbons for metered-dose inhalers for the treatment of asthma and chronic obstructive pulmonary disease to present to the Ozone Secretariat an initial national or regional transition strategy by 31 January 2010 for circulation to all Parties. Where possible, Parties operating under paragraph 1 of Article\xc2\xa05 are encouraged to develop and submit to the Secretariat an initial transition strategy by 31\xc2\xa0January 2009. In preparing a transition strategy, Parties operating under paragraph 1 of Article 5 should take into consideration the availability and price of treatments for asthma and chronic obstructive pulmonary disease in countries currently importing chlorofluorocarbon-containing metered-dose inhalers;    (f)\xc2\xa0 To add a new paragraph after paragraph 2 of decision XII/2 to read as follows:    2  bis.  That any chlorofluorocarbon metered-dose inhaler product approved after 31\xc2\xa0December 2008, excluding any product in the process of registration and approved by 31\xc2\xa0December 2009, for treatment of asthma and/or chronic obstructive pulmonary disease in a Party operating under paragraph 1 of Article 5, is not an essential use, unless the product meets the criteria set out in paragraph\xc2\xa01 (a) of decision IV/25;   (g) To add a new paragraph after paragraph 4 of decision XV/5 to read as follows:  4  bis . That no quantity of chlorofluorocarbons for essential uses shall be authorized after the commencement of the Twenty-First Meeting of the Parties if the nominating Party operating under paragraph 1 of Article 5 has not submitted to the Ozone Secretariat, in time for consideration by the Parties at the twenty-ninth meeting of the Open-ended Working Group, a preliminary plan of action regarding the phase-out of the domestic use of chlorofluorocarbon\xe2\x80\x91containing metered-dose inhalers where the sole active ingredient is salbutamol;      2.\xc2\xa0\xc2\xa0 That both the Parties submitting nominations for essential-use exemptions and the Technology and Economic Assessment Panel reviewing nominations for essential-use exemptions shall consider the decisions noted above in their amended form when considering essential-use nominations in 2009 and beyond, subject to any further future decisions of the Parties;    3. \xc2\xa0 To request the Secretariat to include the changes above in the relevant decisions of the Parties contained in the Montreal Protocol handbook at the time of its next revision, and to note in that handbook that the related decisions include the modifications adopted by the present decision;  4.\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0\xc2\xa0 To request the Technology and Economic Assessment Panel to reflect paragraphs 1\xe2\x80\x933 above in a revised version of the handbook on essential-use nominations and to submit, for consideration by Parties, suggestions for any appropriate changes to the handbook and the timing to make such changes;